Anne C. Fleischer is CEO & Managing Partner of the newly established impact fund Cancer Impact Ventures, working at the intersection of health, innovation, investment, and real-world impact. Her work focuses on translating advances in cancer research, prevention, treatment, and care into meaningful outcomes for patients and society—by building and investing in businesses that can drive lasting change. With a background spanning healthcare, innovation, and business, Anne is passionate about challenging traditional approaches to cancer care and treatment and shaping more sustainable, human-centred solutions across the health ecosystem. She brings a strong focus on collaboration across disciplines and sectors, and on turning ambition and innovation into tangible change. Prior to focusing on cancer, Anne led Consumer Engagement & New Business Models at Novo Nordisk, contributing to the global launch of innovative weight-management medicines. Based in Copenhagen and working internationally, Anne is committed to advancing new conversations, investing in ventures, fostering collaboration, and driving system innovation to help shape the future of cancer care and health.